Literature DB >> 32816782

Correction: Metformin limits osteoarthritis development and progression through activation of AMPK signalling.

.   

Abstract

Entities:  

Year:  2020        PMID： 32816782      PMCID： PMC7854926          DOI： 10.1136/annrheumdis-2019-216713corr1

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

Review 1.  Metformin as a Treatment Strategy for Sjögren's Syndrome.

Authors:  Joa Kim; Yun-Sung Kim; Sung-Hwan Park
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.